Literature DB >> 28642306

"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary." Claus F. Vogelmeier, Gerard J. Criner, Fernando J. Martinez, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Rongchang Chen, Marc Decramer, Leonardo M. Fabbri, Peter Frith, David M.G. Halpin, M. Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D. Sin, Dave Singh, Robert Stockley, Jørgen Vestbo, Jadwiga A. Wedzicha and Alvar Agusti. Eur Respir J 2017; 49: 1700214.

.   

Abstract

Entities:  

Year:  2017        PMID： 28642306     DOI： 10.1183/13993003.50214-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

1.  A feasibility pragmatic clinical trial of a primary care network exercise and education program for people with COPD.

Authors:  Kelsey M T Hurley; Anne-Marie Selzler; Wendy M Rodgers; Michael K Stickland
Journal:  Pilot Feasibility Stud       Date:  2020-10-26

2.  Grading Severity of Productive Cough Based on Symptoms and Airflow Obstruction.

Authors:  Rodrigo Vazquez Guillamet; Hans Petersen; Paula Meek; Akshay Sood; Yohannes Tesfaigzi
Journal:  COPD       Date:  2018-04-26       Impact factor: 2.409

3.  Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet Respir Med       Date:  2017-08-16       Impact factor: 30.700

4.  The impact of integrated disease management in high-risk COPD patients in primary care.

Authors:  Madonna Ferrone; Marcello G Masciantonio; Natalie Malus; Larry Stitt; Tim O'Callahan; Zofe Roberts; Laura Johnson; Jim Samson; Lisa Durocher; Mark Ferrari; Margo Reilly; Kelly Griffiths; Christopher J Licskai
Journal:  NPJ Prim Care Respir Med       Date:  2019-03-28       Impact factor: 2.871

5.  PD-L1, FGFR1, PIK3CA, PTEN, and p16 expression in pulmonary emphysema and chronic obstructive pulmonary disease with resected lung squamous cell carcinoma.

Authors:  Ken Arimura; Yasuo Sekine; Kenzo Hiroshima; Satoru Shimizu; Noriyuki Shibata; Mitsuko Kondo; Kiyoshi Takeyama; Etsuko Tagaya
Journal:  BMC Pulm Med       Date:  2019-09-03       Impact factor: 3.317

6.  The Impact of COPD Exacerbations in the Year Following Pulmonary Rehabilitation: Secondary Analysis of a Randomised Controlled Trial.

Authors:  Bruna Wageck; Narelle S Cox; Christine F McDonald; Angela T Burge; Ajay Mahal; Catherine J Hill; Annemarie L Lee; Rosemary Moore; Caroline Nicolson; Paul O'Halloran; Aroub Lahham; Rebecca Gillies; Anne E Holland
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-31

7.  Environmental triggers of COPD symptoms: a case cross-over study.

Authors:  Susan R Sama; David Kriebel; Rebecca J Gore; Rebecca DeVries; Richard Rosiello
Journal:  BMJ Open Respir Res       Date:  2017-07-03

8.  Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure.

Authors:  Frits M E Franssen; Lowie E G W Vanfleteren; Daisy J A Janssen; Emiel F M Wouters; Martijn A Spruit
Journal:  Breathe (Sheff)       Date:  2019-09

9.  Chronic obstructive pulmonary disease prevalence and associated factors in an urban HIV clinic in a low income country.

Authors:  Ahmed Ddungu; Fred C Semitala; Barbara Castelnuovo; Christine Sekaggya-Wiltshire; William Worodria; Bruce J Kirenga
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.